Posted by Michael Wonder on 26 Jul 2023
ICER releases draft evidence report on treatment for metachromatic leukodystrophy
26 July 2023 - Registration now open for 3 August “Early Insights” webinar.
The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of atidarsagene autotemcel (Orchard Therapeutics) for metachromatic leukodystrophy. This preliminary draft marks the midpoint of ICER’s eight month process of assessing these treatments, and the findings within this document should not be interpreted to be ICER’s final conclusions.
